TOMSK, RUSSIA / RankWire.AI / – Russian scientists have evaluated a bioactive coating aimed at enhancing the integration of titanium orthopedic implants with bone tissue. This material incorporates calcium phosphate derived from hydroxyapatite and contains nitrogen compounds linked to nitric oxide production. Laboratory experiments demonstrated significantly improved survival rates of human mesenchymal stem cells on surfaces coated with this material compared to uncoated titanium. The team analyzed the coating’s structure, chemical makeup, mechanical characteristics, and biological response. Their peer-reviewed results were published in Applied Surface Science in 2026.
At Tomsk Polytechnic University, researchers created the experimental coatings through reactive magnetron sputtering of a hydroxyapatite target within a vacuum chamber. They adjusted the nitrogen and argon gas ratios during deposition to observe how each mixture influenced the resulting surface properties. The study tested five different conditions, from pure nitrogen to pure argon. They then measured parameters such as coating thickness, surface morphology, hardness, wettability, and chemical composition. Additionally, they conducted laboratory tests to evaluate the biological response of living human cells to the modified titanium surfaces.
The results revealed that varying the argon content affected several physical features of the coatings. Surfaces produced in pure argon were denser and harder than those formed in pure nitrogen. As the proportion of argon increased, so did the coating thickness. Chemical analysis identified nitrogen-carbon and nitrogen-oxygen bonds on the modified surfaces. The team then compared the growth of human mesenchymal stem cells on coated titanium with their growth on uncoated titanium. The biological assessments focused on cell viability and markers associated with bone-cell development.
Coating evaluations indicate enhanced cell viability
According to the study, cell experiments showed that coated surfaces significantly outperformed uncoated titanium in terms of cell survival. After seven days, coatings with higher nitrogen content also suppressed activity in certain genes linked to early bone-cell differentiation. Despite this, the cells maintained their ability to form bone tissue. These observations were made under controlled laboratory conditions using human mesenchymal stem cells. The study did not include tests on actual patients or assess the clinical performance of medical implants.
The biomedical evaluation was carried out by researchers from Immanuel Kant Baltic Federal University and Siberian State Medical University, with additional contributions from Saint Petersburg State University. The project received backing through Russia’s national science program. The scientists aimed to identify gas mixtures that could produce optimal combinations of physical, chemical, and biological properties in coatings. Hydroxyapatite, due to its calcium phosphate structure resembling human bone mineral, already finds applications in implant coatings.
Further testing beyond initial laboratory results planned
The research team plans to extend their investigations beyond the initial seven-day cell culture tests. They intend to analyze stem cell behavior over periods ranging from 10 to 28 days. Additionally, they aim to examine how rapidly the coatings dissolve and to measure nitric oxide release into surrounding tissues in vivo. These future studies were not included in the current publication. Presently, the research focuses on coated titanium substrates, their physical and chemical properties, and in vitro cellular responses, rather than clinical outcomes related to orthopedic implants.
The results offer comprehensive laboratory data on how different ratios of nitrogen and argon influence calcium phosphate coatings on titanium surfaces. Variations in thickness, density, hardness, chemical bonds, and cellular responses across different gas mixtures were documented. The findings also show that coated samples support higher stem-cell survival compared to uncoated titanium under laboratory conditions. However, the research remains at a preclinical stage, and the published experiments do not establish the safety or efficacy of these coatings in human patients. Additional biological testing will be necessary to evaluate properties not addressed in this study.